Literature DB >> 15485551

Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.

Isaac Túnez1, Pedro Montilla, M Del Carmen Muñoz, Montserrat Feijóo, Manuel Salcedo.   

Abstract

The effect of melatonin (1 mg/kg BW i.p./day) on the oxidative changes produced by 3-nitropropionic acid (20 mg/kg BW/day for 4 days) in rat striatal and cortical synaptosomes was investigated. The effects of 3-nitropropionic acid were evaluated as changes in the quantity of lipid peroxidation products, protein carbonyl groups and superoxide dismutase and succinate dehydrogenase activities. 3-Nitropropionic acid caused a rise in lipid peroxidation levels and protein carbonyls content whereas it induced a reduction in the activity of succinate dehydrogenase and triggered an enhancement in superoxide dismutase activity. These changes were prevented by previous administration of melatonin. Our results reveal: (i) 3-nitropropionic acid induces a status of oxidative stress in some brain regions of the Wistar rat; (ii) melatonin prevents the deleterious effects induced by the acid. In conclusion, the results show the ability of melatonin to modify the neural response to 3-nitropropionic acid with the protective mechanism likely involving the antioxidative processes of melatonin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485551     DOI: 10.1111/j.1600-079X.2004.00163.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  33 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 2.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

3.  Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.

Authors:  I Tasset; C Espínola; F J Medina; M Feijóo; C Ruiz; E Moreno; M M Gómez; J A Collado; C Muñoz; J Muntané; P Montilla; I Túnez
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

4.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

Review 5.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

6.  Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.

Authors:  Rajat Sandhir; Aarti Yadav; Arpit Mehrotra; Aditya Sunkaria; Amandeep Singh; Sadhna Sharma
Journal:  Neuromolecular Med       Date:  2013-09-06       Impact factor: 3.843

7.  Viper venom-induced oxidative stress and activation of inflammatory cytokines: a therapeutic approach for overlooked issues of snakebite management.

Authors:  M Sebastin Santhosh; M Shanmuga Sundaram; K Sunitha; K Kemparaju; K S Girish
Journal:  Inflamm Res       Date:  2013-05-09       Impact factor: 4.575

8.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

9.  Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells.

Authors:  Attila Bacsi; Mitchell Woodberry; William Widger; John Papaconstantinou; Sankar Mitra; Johnny W Peterson; Istvan Boldogh
Journal:  Mitochondrion       Date:  2006-08-03       Impact factor: 4.160

10.  Delayed onset of the diurnal melatonin rise in patients with Huntington's disease.

Authors:  N Ahmad Aziz; Hanno Pijl; Marijke Frölich; Janny P Schröder-van der Elst; Chris van der Bent; Ferdinand Roelfsema; Raymund A C Roos
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.